Re Agreement

Plant Health Care PLC
21 January 2008



For release: 21 January 2008

                              PLANT HEALTH CARE PLC
                     ('Plant Health Care' or 'the Company')

      Bayer CropScience moves forward with second year of Myconate(R) tests
                                       

Plant Health Care (AIM: PHC.L), a leading provider of natural products for
plants and soil, announces that following the 2007 trial results, Bayer
CropScience has confirmed that it will move forward with the second year of
Myconate(R) testing. Bayer CropScience will be making a milestone payment to
Plant Health Care for the continuation of the cooperation into the second year.
Financial details were not disclosed.

Bayer CropScience, the global leader in seed treatment products, offers a broad
portfolio of high-quality products to combat pests and fungal diseases. Plant
Health Care's Myconate(R) technology is known to help crops to develop larger
root mass through the stimulation of naturally occurring mycorrhizal fungi,
which in turn often leads to improved yields and enhanced stress resistance.
Both companies are collaborating on the further development of Myconate(R) as a
seed treatment product in corn, soybean, cotton and sunflower on a worldwide
basis.

Commenting, John Brady, Chief Executive of Plant Health Care said: 'We are
excited that Bayer CropScience has elected to move forward with the development
and trial programme and we look forward to working with them to further develop
the commercial potential of Myconate(R).'

                                     -Ends-


For further information please contact:

Plant Heath Care plc          Tavistock               Evolution Securities
                              Communications          Limited
John Brady, Chief Executive   Jeremy Carey/Matt       Tim Worlledge/ Tim
                              Ridsdale                Redfern
Tel: [phone]            Tel: [phone]      Tel: [phone]
(21 - 25 January)
Tel: [phone]
(Thereafter)




                      This information is provided by RNS
            The company news service from the London Stock Exchange